TABLE 1.
Effect of combining IL-12 with low-dose AMB treatmenta
Treatment | Low-dose AmB | Liver parasite burden (LDU)
|
% Killing | |
---|---|---|---|---|
Day +14 | Day +21 | |||
None | − | 1,346 ± 68 | 1,514 ± 148 | 0 |
None | + | 1,086 ± 79 | 19 | |
IL-12 | − | 893 ± 126 | 33 | |
IL-12 | + | 242 ± 52b | 82 | |
Saline | + | 1231 ± 129 | 9 | |
AMB (optimal) | 107 ± 28b | 92 |
At 12 days after infection, mice received no therapy or were started on pump-delivered IL-12 or saline treatment. Low-dose AMB (1 mg/kg) was given on days +14 and +17; optimal AMB (5 mg/kg) was given on days +14, +16, and +18. The results are from two experiments and indicate the mean ± standard errors of the means for a total of 7 to 11 mice per group at each time point.
P < 0.05 versus the value on day +14.